NM_152891.3:c.511G>A

Variant summary

Our verdict is Likely benign. The variant received -1 ACMG points: 0P and 1B. BP4

The NM_152891.3(PRSS33):​c.511G>A​(p.Gly171Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000223 in 1,435,628 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00014 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00023 ( 0 hom. )

Consequence

PRSS33
NM_152891.3 missense

Scores

2
9
8

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 2.67

Publications

0 publications found
Variant links:
Genes affected
PRSS33 (HGNC:30405): (serine protease 33) Enables serine-type endopeptidase activity. Involved in protein kinase C signaling and proteolysis. Located in cytoplasm. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -1 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.3251556).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PRSS33NM_152891.3 linkc.511G>A p.Gly171Arg missense_variant Exon 5 of 7 ENST00000682474.1 NP_690851.2 Q8NF86

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PRSS33ENST00000682474.1 linkc.511G>A p.Gly171Arg missense_variant Exon 5 of 7 NM_152891.3 ENSP00000507560.1 Q8NF86

Frequencies

GnomAD3 genomes
AF:
0.000145
AC:
22
AN:
152210
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000965
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000221
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000177
AC:
9
AN:
50990
AF XY:
0.000186
show subpopulations
Gnomad AFR exome
AF:
0.000268
Gnomad AMR exome
AF:
0.000115
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000208
Gnomad OTH exome
AF:
0.000627
GnomAD4 exome
AF:
0.000232
AC:
298
AN:
1283418
Hom.:
0
Cov.:
33
AF XY:
0.000218
AC XY:
136
AN XY:
624982
show subpopulations
African (AFR)
AF:
0.0000373
AC:
1
AN:
26778
American (AMR)
AF:
0.000108
AC:
2
AN:
18468
Ashkenazi Jewish (ASJ)
AF:
0.000164
AC:
3
AN:
18348
East Asian (EAS)
AF:
0.00
AC:
0
AN:
32944
South Asian (SAS)
AF:
0.0000961
AC:
6
AN:
62408
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
30476
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3858
European-Non Finnish (NFE)
AF:
0.000267
AC:
277
AN:
1036972
Other (OTH)
AF:
0.000169
AC:
9
AN:
53166
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
18
37
55
74
92
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000145
AC:
22
AN:
152210
Hom.:
0
Cov.:
33
AF XY:
0.000148
AC XY:
11
AN XY:
74360
show subpopulations
African (AFR)
AF:
0.0000965
AC:
4
AN:
41456
American (AMR)
AF:
0.000131
AC:
2
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.000288
AC:
1
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5196
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4834
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.000221
AC:
15
AN:
68018
Other (OTH)
AF:
0.00
AC:
0
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000139
Hom.:
0
Bravo
AF:
0.000132
ExAC
AF:
0.0000840
AC:
8

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Apr 19, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.511G>A (p.G171R) alteration is located in exon 4 (coding exon 4) of the PRSS33 gene. This alteration results from a G to A substitution at nucleotide position 511, causing the glycine (G) at amino acid position 171 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.33
BayesDel_addAF
Benign
-0.069
T
BayesDel_noAF
Uncertain
-0.040
CADD
Uncertain
24
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.44
T;T;D
Eigen
Uncertain
0.30
Eigen_PC
Uncertain
0.29
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Benign
0.60
.;T;T
M_CAP
Pathogenic
0.62
D
MetaRNN
Benign
0.33
T;T;T
MetaSVM
Uncertain
0.46
D
MutationAssessor
Benign
1.6
L;L;.
PhyloP100
2.7
PrimateAI
Pathogenic
0.79
T
PROVEAN
Benign
-1.6
N;.;.
REVEL
Uncertain
0.64
Sift
Benign
0.091
T;.;.
Sift4G
Uncertain
0.050
T;T;.
Polyphen
0.85
P;P;.
Vest4
0.33
MutPred
0.44
Gain of solvent accessibility (P = 0.0037);Gain of solvent accessibility (P = 0.0037);.;
MVP
0.78
MPC
1.2
ClinPred
0.13
T
GERP RS
4.6
Varity_R
0.12
gMVP
0.72
Mutation Taster
=64/36
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs768346321; hg19: chr16-2835379; API